Cargando…
Colchicine for the prevention of COVID-19 “hard” outcomes: All that glitters is not gold
Autores principales: | Patoulias, Dimitrios, Papadopoulos, Christodoulos, Karagiannis, Asterios, Doumas, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612820/ https://www.ncbi.nlm.nih.gov/pubmed/34848120 http://dx.doi.org/10.1016/j.ejim.2021.11.016 |
Ejemplares similares
-
Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study
por: Patoulias, Dimitrios, et al.
Publicado: (2022) -
Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials
por: Patoulias, Dimitrios, et al.
Publicado: (2021) -
Endothelial dysfunction and COVID-19: What's the true impact on surrogate outcomes?
por: Patoulias, Dimitrios, et al.
Publicado: (2022) -
Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
por: Patoulias, Dimitrios, et al.
Publicado: (2022) -
Academic nepotism - all that glitters is not gold
por: KUMAR. V, DINESH
Publicado: (2018)